BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

94 related articles for article (PubMed ID: 10958987)

  • 1. Rubella virus nonstructural protein 2 is a minor immunogen.
    Hofmann J; Gerstenberger S; Lachmann I; Atreya CD; Liebert UG
    Virus Res; 2000 Jul; 68(2):155-60. PubMed ID: 10958987
    [TBL] [Abstract][Full Text] [Related]  

  • 2. A recombinant rubella virus E1 glycoprotein as a rubella vaccine candidate.
    Perrenoud G; Messerli F; Thierry AC; Beltraminelli N; Cousin P; Fasel N; Vallet V; Demotz S; Duchosal MA; Moulon C
    Vaccine; 2004 Dec; 23(4):480-8. PubMed ID: 15530696
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Rubella virus P90 associates with the cytokinesis regulatory protein Citron-K kinase and the viral infection and constitutive expression of P90 protein both induce cell cycle arrest following S phase in cell culture.
    Atreya CD; Kulkarni S; Mohan KV
    Arch Virol; 2004 Apr; 149(4):779-89. PubMed ID: 15045564
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Application of antibodies against nonstructural protein 2B of dengue serotype 2 virus induced by DNA immunisation or recombinant protein NS 2B immunisation in BALB/c mice.
    Liu L; Tian Y; Gao N; Chen Zt; Zhang H; An J
    J Virol Methods; 2010 Jan; 163(1):10-6. PubMed ID: 19406165
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Identification of the rubella virus nonstructural proteins.
    Forng RY; Frey TK
    Virology; 1995 Feb; 206(2):843-53. PubMed ID: 7856097
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Reactivity of a recombinant rubella E1 antigen expressed in E. coli.
    Londesborough P; Terry G; Ho-Terry L
    Arch Virol; 1992; 122(3-4):391-7. PubMed ID: 1731700
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Proteolytic processing of rubella virus nonstructural proteins.
    Yao J; Yang D; Chong P; Hwang D; Liang Y; Gillam S
    Virology; 1998 Jun; 246(1):74-82. PubMed ID: 9656995
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Immunization of Mice by Rotavirus NSP4-VP6 Fusion Protein Elicited Stronger Responses Compared to VP6 Alone.
    Afchangi A; Arashkia A; Shahosseini Z; Jalilvand S; Marashi SM; Roohvand F; Mohajel N; Shoja Z
    Viral Immunol; 2018 Apr; 31(3):233-241. PubMed ID: 29185875
    [TBL] [Abstract][Full Text] [Related]  

  • 9. [The Preparation of Epitope-based Recombinant Rubella Virus Diagnostic Antigen].
    Su Q; Guo M; Qiu F; Jia Z; Lu X; Meng Q; Tian R; Bi S; Yi Y
    Bing Du Xue Bao; 2016 May; 32(3):249-55. PubMed ID: 29962194
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Immunoaffinity purification of baculovirus-expressed rubella virus E1 for diagnostic purposes.
    Lindqvist C; Schmidt M; Heinola J; Jaatinen R; Osterblad M; Salmi A; Keränen S; Akerman K; Oker-Blom C
    J Clin Microbiol; 1994 Sep; 32(9):2192-6. PubMed ID: 7814545
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Cell-fusion assay for the detection of rubella virus in Vero cells.
    Grutadauria S; Cordoba P; Cuffini C; Zapata M
    Clin Diagn Virol; 1998 May; 10(1):9-16. PubMed ID: 9645998
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Neutralizing monoclonal antibody to the E1 glycoprotein epitope of rubella virus mediates virus arrest in VERO cells.
    Cordoba P; Grutadauria S; Cuffini C; Zapata M
    Viral Immunol; 2000; 13(1):83-92. PubMed ID: 10733171
    [TBL] [Abstract][Full Text] [Related]  

  • 13. [Expression of recombinant rubella virus E1 protein and initial application for detecting of antibody].
    Yi Y; Guo MZ; Yu T; Xu WB; Yang JY; Chen SY
    Zhonghua Shi Yan He Lin Chuang Bing Du Xue Za Zhi; 2008 Oct; 22(5):382-4. PubMed ID: 19469182
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Vaccinia virus-expressed bovine ephemeral fever virus G but not G(NS) glycoprotein induces neutralizing antibodies and protects against experimental infection.
    Hertig C; Pye AD; Hyatt AD; Davis SS; McWilliam SM; Heine HG; Walker PJ; Boyle DB
    J Gen Virol; 1996 Apr; 77 ( Pt 4)():631-40. PubMed ID: 8627251
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Comparison of immune response to rubella virus proteins in early and late natural infections.
    Nates SV; Mersich SE; Damonte EB; Zapata MT
    Microbiologica; 1989 Oct; 12(4):335-8. PubMed ID: 2578031
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Rubella virus RNA replication is cis-preferential and synthesis of negative- and positive-strand RNAs is regulated by the processing of nonstructural protein.
    Liang Y; Gillam S
    Virology; 2001 Apr; 282(2):307-19. PubMed ID: 11289813
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Use of rubella virus E1 fusion proteins for detection of rubella virus antibodies.
    Starkey WG; Newcombe J; Corbett KM; Liu KM; Sanders PG; Best JM
    J Clin Microbiol; 1995 Feb; 33(2):270-4. PubMed ID: 7714176
    [TBL] [Abstract][Full Text] [Related]  

  • 18. The influence of N-linked glycosylation on the antigenicity and immunogenicity of rubella virus E1 glycoprotein.
    Qiu Z; Tufaro F; Gillam S
    Virology; 1992 Oct; 190(2):876-81. PubMed ID: 1381541
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Study of rubella candidate vaccine based on a structurally modified plant virus.
    Trifonova EA; Zenin VA; Nikitin NA; Yurkova MS; Ryabchevskaya EM; Putlyaev EV; Donchenko EK; Kondakova OA; Fedorov AN; Atabekov JG; Karpova OV
    Antiviral Res; 2017 Aug; 144():27-33. PubMed ID: 28511994
    [TBL] [Abstract][Full Text] [Related]  

  • 20. [Protective activity of a bacterial plasmid, bearing the gene for the tick-borne encephalitis virus NS1 nonstructural protein].
    Timofeev AV; Kondrat'eva IuIu; Karganova GG; Stephenson J
    Vopr Virusol; 2001; 46(1):22-4. PubMed ID: 11233282
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 5.